Dijkstra, Anke A. http://orcid.org/0000-0003-2160-587X
Morrema, Tjado H. J.
Hart de Ruyter, Frederique J.
Gami-Patel, Priya
Verbraak, Frank D.
de Boer, Johannes F.
Bouwman, Femke H.
Pijnenburg, Yolande A. L.
den Haan, Jurre
Rozemuller, Annemieke J.
Hoozemans, Jeroen J. M.
Funding for this research was provided by:
Alzheimer Nederland (WE.03-2021-14)
Article History
Received: 10 May 2023
Revised: 8 August 2023
Accepted: 8 August 2023
First Online: 19 August 2023
Declarations
:
: Anke A. Dijkstra, Tjado H. J. Morrema, Frederique Hart-de Ruijter, Priya Gami-Patel, Frank D. Verbraak, Jurre den Haan, and Annemieke J. Rozemuller report no competing interests; Prof. dr. J. F. de Boer has acquired grant support (for the institution; Department of Physics, VU) from the Dutch Research Council (NWO) and from industry (Thorlabs, ASML, Heidelberg Engineering). He has received royalties related to IP on OCT technologies and semiconductor metrology. He has acted as an expert witness for a UK-based law firm; Dr. F. Bouwman performs contract research for Optina Dx and Optos, she has been an invited speaker at Roche and has been invited for expert testimony at Biogen. All funding is paid to her institution; Dr. J. J. M. Hoozemans received grants from the Dutch Research Council (ZonMW) and, Alzheimer Netherlands, performed contract research or received grants from Merck, ONO Pharmaceuticals, Janssen Prevention Center, DiscovericBio, AxonNeurosciences, Roche, Genentech, Promis, Denali, First Biotherapeutics, and Ensol Biosciences. All payments were made to the institution. Dr. J. J. M. Hoozemans participates in the scientific advisory board of Alzheimer Netherlands and is editor-in-chief for Acta Neuropathologica Communications.
: Prior to death donors signed informed consent for brain and eye autopsy and use of brain and eye tissue as well as medical records for research activities. This study was approved by the medical ethical committee of the VUmc (reference# 2009/148).